COMMON STOCK |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COMMON STOCK | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COMMON STOCK | 15. COMMON STOCK Common Stock Offering On July 3, 2025, the Company entered into the Distribution Agreement, pursuant to which the Company may offer and sell shares of its common stock having an aggregate offering price of up to $50.0 million from time to time through the ATM Program. Sales under the Distribution Agreement will be made pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-288526) and a related prospectus and prospectus supplement. During the nine months ended September 30, 2026, the Company sold an aggregate of 6,247,772 shares of its common stock under the ATM Program at an average price of $1.37 per share, generating gross proceeds of $8.6 million. The Company paid $0.2 million in aggregate sales commissions and incurred $0.2 million of additional offering-related expenses, of which $0.1 million related to the amortization of shelf registration costs associated with the ATM program. As of September 30, 2026, net proceeds from the offering were $8.2 million. As of September 30, 2026, the Company had approximately $33.1 million remaining available for future issuance under the ATM Program. Common Stock The following table summarizes the total number of shares of the Company’s common stock issued and reserved for issuance as of September 30, 2026 and December 31, 2025 (in thousands):
Common Stock Warrants The following table summarizes the Company’s outstanding common stock warrants as of September 30, 2026 and December 31, 2025:
There have been no grants, exercises, or cancellations of warrants during the three and nine months ended September 30, 2026. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||